Graftys

Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. The Companys products are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnership. The objective of the Company is to expand the Company product lines by offering new versions of existing products and new products with enhanced regenerative properties. The Company is based in Belgium (Wallonia) and France (Nantes and Aix-En-Provence)

Bone graft substitutes,bone void fillers,orthopedics,reconstructive orthopedic surgery,trauma,bone tissue engineering,injectable bone substitutes,biomaterials,and medical device

Graftys operates in the Medical device industry.

Graftys's revenue is 1m - 10m

Graftys has 11 - 50 employees.